The Cambridge Taiwanese Chamber of Commerce (CTCC) is a non-profit business organisation representing Taiwanese enterprises and professionals across Greater Cambridge and the wider East Anglia region. Rooted in one of Europe’s foremost centres of research and innovation, CTCC serves as the principal point of connection for Taiwan-linked business activity in the area.
Our community brings together founders, executives, investors, researchers, and independent professionals whose work spans the deep-tech, life sciences, and high-growth sectors that define the Cambridge cluster. Whether members are establishing a UK presence, scaling an existing operation, or seeking trusted peers in the local ecosystem, CTCC provides the relationships and regional context to do so with confidence.
Membership is offered through three tiers — Ordinary, Supporting, and Strategic Corporate Partner — accommodating individual professionals, contributing partners, and headline corporate sponsors. Members benefit from networking events, closed-door briefings, introductions to local institutions and policymakers, and a collective platform that gives Taiwanese business a voice in the region.
CTCC is governed by an elected Council under a published constitution that ensures transparent decision-making, sound financial stewardship, and accountability to its members. We welcome enquiries from prospective members and partners committed to building meaningful Taiwan–UK business ties.
Mission Statement
To realize our vision of shared prosperity, CTCC is committed to the following four mission statements:
Market Entry & Strategic Matchmaking: Facilitating the successful landing of Taiwan’s flagship enterprises across high-value sectors—including Semiconductors & AI Data Technologies, Biomedicine & CDMO, Precision Medicine & Smart Long-Term Care, and Sustainable Green Energy—in Cambridge. We provide precise market entry consultancy, business matchmaking, and localized resource support.
Bilateral Industry-Academia Translation & Global Market Expansion: Deepening strategic partnerships with prestigious local academic institutions and UK research, government, and industry organizations. We promote the “Taiwanese R&D, UK Validation” and “UK R&D, Taiwanese Manufacturing” models, accelerating the translation and localized validation of pioneering technologies while leveraging Taiwan’s industrial strengths to help UK innovations expand into Asian and global markets.
Trade Advocacy & Resource Integration: Strengthening communication with government authorities and trade organizations in both Taiwan and the UK, advocating for member interests and enhancing the economic influence of Taiwanese businesses.
Talent Empowerment & Community Connection: Building a cross-generational knowledge-sharing platform and facilitating bilateral internship and exchange programs for students, academic talents, and enterprises across diverse sectors. By partnering with alumni and professional associations, we aim to nurture the next generation of global tech and business leaders within the Cambridge ecosystem.
Our Committee
Dr. Ming-Tsung (Louis) Wu is a scientist-entrepreneur and a prominent leader in the global Taiwanese business landscape. A graduate of Cambridge’s Impulse Program, he co-founded GeneNet Technology, navigating its growth from the Stevenage Bioscience Catalyst Lab Hotel to its current base at the Milner Therapeutics Institute, University of Cambridge. Under his leadership, GeneNet was honored as a Final Top 5 Winner in the IC Taiwan Grand Challenge (ICGTC). Louis possesses a stellar track record in international R&D management, serving as UK Industry Project Lead and co-PI for EUREKA GlobalStars (2022-2024). He currently co-spearheads UK-Taiwan Collaborative R&D (2025-2026) in partnership with the UK Center for Process Innovation (CPI), Medicines Discovery C atapult (MDC), and Taiwan Industrial Technology Research Institute (ITRI). His extensive leadership in trade organizations includes serving as Secretary General and VP of UKTCC, VP of Monte Jade Europe Science & Technology Association, and VP of the ESG Committee at WTCC. As President of the NTU Alumni Association UK, he pioneered Taiwan’s first university-level overseas internship program at leading international research centres. Leveraging his “Academic-Industry-Government” trifecta, Louis bridges top-tier innovation and capital on the global stage.
Wen Nivala is a Taiwanese British serial entrepreneur, product designer, and angel investor focused on wellness technology and human centered innovation. With backgrounds spanning engineering, design, and business, Wen has built companies across both B2B and B2C markets, with experience in high tech industries, sensor technology, consumer products, and global distribution channels. Wen studied in Taiwan, earned a PhD in Product Design from De Montfort University in the UK, and completed an EMBA at University of Chicago Booth School of Business. Throughout Wen’s entrepreneurial journey, the companies and products involved have received international recognition, including a Finnish Presidential award, the Queen’s Awards for Enterprise, and the iF Design Award. Wen previously co founded MEATER, an award winning smart thermometer company, and now leads Flowgreens
, creator of ScentXpresso, a smart in shower aromatherapy system designed to bring instant relaxation and wellbeing into daily life.
Currently serving as Managing Director of RegalStar Catering Ltd, operational oversight, and business growth strategies within the hospitality and catering sector. Alongside commercial leadership, actively contributes to charitable and community-focused initiatives as Vice-Chair of The Saints Projects Trust. Appointment as Adviser to the Overseas Community Affairs Council, Taiwan (R.O.C.), strengthening cultural collaboration and communication. As Founder and Chair of the Cambridge Taiwanese Association, established and developed a platform promoting cultural exchange, community Networking.
Former Deputy General Manager, Tatung UK, overseeing EMEA operations, key accounts, and cross‑border commercial execution. Former European Sales Director, Pegatron Group, leading regional business development, customer engagement, and strategic growth initiatives. Extensive experience across the electronics, aerospace, and semiconductor sectors, with strong understanding of global supply chains and high‑reliability manufacturing environments. Professional background includes procurement roles at BAE Systems, Rolls‑Royce, and Patton Air, with proven capability in supplier management, contract negotiation, and compliance processes
I-Shuo Chen is a Senior Lecturer in Organisational Behaviour at Anglia Ruskin University, Cambridge, UK, where he also serves as Faculty Lead for Health Performance and Wellbeing within the RII Leadership Team and as the Faculty representative on the Human Biological Materials Committee. He is also Chair of the Organizational Behavior Division of the Institute of Business and Applied Management, USA. Before joining Anglia Ruskin University, Dr Chen held academic positions as Lecturer in Management at the University of Dundee, UK, and Assistant Professor in Organisational Behaviour at Wuhan University, Mainland China. He obtained his PhD in Business Studies, specialising in Organisational Behaviour, from the AACSB-accredited School of Business at Trinity College Dublin, Ireland, and holds an MBA from the AACSB-accredited National Chiao Tung University, Taiwan. He has also been a visiting scholar at the University of Tokyo and Kobe University, Japan, and Seoul National University, South Korea. His research focuses on leisure crafting, playful work design, job and home boredom, work engagement, creativity, and job performance. He serves as an Academic Editor for Human Behavior and Emerging Technologies and has reviewed for a wide range of leading journals, including Human Relations, among others.
Dr. Weiluo Lee currently serves as Global Lead for Veterinary Drug Development at Pilatus Biosciences, a drug startup pioneering first-in-class biologics targeting metabolic checkpoints to advance cancer immunotherapy. Previously, he was COO of Axitan, a microalgae biotech company focused on eliminating antibiotics from animal feed and improving productivity using its novel antimicrobial microalgae/enzyme formulation. As part of the founding leadership team, he took on a wide range of leading roles to advance Axitan’s mission – R&D, manufacturing operations, regulations, and supply chain activities. He graduated from University College London with a PhD in biochemical engineering and received a BSc in chemical engineering from the University of California, Berkeley.